跳转至内容
Merck
CN

SML4314

Procyanidin B1

≥98% (HPLC)

别名:

(+)-Procyanidin B1, (2R,2′R,3R,3′S,4R)-2,2′-Bis(3,4-dihydroxyphenyl)-3,3′,4,4′-tetrahydro[4,8′-bi-2H-1-benzopyran]-3,3′,5,5′,7,7′-hexol, (-)-Epicatechin-(4β-8)-(+)-catechin, Epicatechin 4β-8 catechin, Proanthocyanidin B1, PCB1, PB1

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C30H26O12
化学文摘社编号:
分子量:
578.52
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

-10 to -25°C

Quality Level

Biochem/physiol Actions

Procyanidin B1, a natural biflavonoid, functions as a potent antioxidant and anti-inflammatory agent, mitigating oxidative stress and inflammation associated with chronic diseases. It exhibits multi-target activity, directly interacting with enzymes like Caspases and COX-2, the Kv10.1 ion channel (IC50 ~10 µM), and the TLR4/MD-2 complex, while inhibiting key signaling pathways including NF-κB, MAPK, and PI3K/Akt. Mechanistically, Procyanidin B1 promotes cancer cell apoptosis (activating Caspase-3, upregulating Bax), potentially regulating ferroptosis via the Nrf2/HO-1/Keap-1 pathway, induces cell cycle arrest (downregulating Cyclins), suppresses inflammatory gene expression (TNF-α, IL-6), provides neuroprotection (effective at 50-100 µM vs Aβ), and regulates metabolic pathways. In vitro and in vivo evidence supports its efficacy in reducing tumor growth and inflammation, demonstrated by decreased biomarkers like TNF-α, IL-6, and Ki67, and increased activated Caspase-3, although systemic delivery faces challenges due to its low cell permeability and oral bioavailability as an intact dimer.

存储类别

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持